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Introduction: The Pittsburgh Sleep Quality Index (PSQI) is a questionnaire that assesses sleep quality and
disturbances over a 1-month period. It is a valuable tool for research purposes. The aim of this study was
to validate a Brazilian Portuguese version of the PSQI.
Methods: The Brazilian Portuguese version (PSQI-BR) was developed according to the following steps: (a)
translation, (b) back-translation, (c) comparison between translation and back-translation performed by
a group of experts, and (d) pretest in bilingual individuals. Between January 2006 and September 2007,
the PSQI-BR was applied to a group of consecutive patients who were submitted to overnight polysom-
nography with clinical suspicion of obstructive sleep apnea syndrome (OSAS) or insomnia. As in the ori-
ginal article, a group of patients with depression and a control group were included. The depression group
was composed of patients from the Mood Disorders Unit of the Psychiatry Department of Hospital de
Clínicas de Porto Alegre (HCPA), Brazil. The control group was composed of subjects with a history of nor-
mal sleep habits, without noticed snoring.
Results: A total of 83 patients and 21 controls completed the questionnaire and were submitted to over-
night polysomnography. The seven-component scores of the PSQI-BR had an overall reliability coefﬁcient
(Cronbach’s a) of 0.82, indicating a high degree of internal consistency. The groups included 43 patients
with OSAS, 21 with insomnia, 19 with depression and 21 controls. The mean (±SD) PSQI-BR score was
8.1 ± 4.0 for patients with OSAS, 12.8 ± 3.7 for insomnia patients, 14.5 ± 3.7 for those with depression
and 2.5 ± 2.0 for control subjects. The one-way ANOVA demonstrated signiﬁcant differences in PSQI-BR
scores across the four diagnostic groups (p < 0.001). Post hoc tests between paired groups showed that
scores for OSAS, depression and insomnia were signiﬁcantly higher than for controls (p < 0.05). PSQI-
BR scores for insomnia did not differ from those obtained for depression (p > 0.05), but both were higher
than for OSAS (p < 0.05).
Conclusions: The results of the present study demonstrate that the PSQI-BR is a valid and reliable instru-
ment for the assessment of sleep quality and equivalent to its original version when applied to individ-
uals who speak the Brazilian Portuguese language. Despite relevant inﬂuences of language and cultural
background, no major cultural adaptations were necessary during the validation process. The PSQI-BR
can be a tool either for clinical management or research.
 2010 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
Neurobiological processes associated with sleep are virtually
necessary in all species for maintenance of physical and cognitive
health. Sleep disorders may cause impairment in school perfor-
mance, work, family and social relationships and are also associ-
ated with increased risk for accidents [1]. For individuals whoOliveira, 330/402, 97050-550
lessa.bertolazzi@hotmail.com
evier OA license.suffer from these disorders, the effect of their symptoms on their
quality of life often prompts them to seek medical attention for
diagnosis and treatment [2,3]. This has encouraged researchers to
develop tools for assessing and further investigating these disor-
ders. But most of these tools have been validated in English and
targeted for English-speaking populations. If one wishes to apply
these tools in other populations, proper cross-cultural adaptation
and validation are required [4–6].
Subjective measurement tools can be used in clinical practice
for diagnostic purposes, for monitoring treatment responses, in
epidemiological studies and in clinical research. Some of them
are designed for the assessment of speciﬁc sleep disorders, such
as sleepiness or presence of awakenings, while others evaluate
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[7]. Assessing sleep quality is a complex task, since it involves
quantitative parameters, such as sleep duration, sleep latency
and number of awakenings, in addition to qualitative parameters,
which are purely subjective.
The Pittsburgh Sleep Quality Index (PSQI) [8], developed by Buy-
sse, appraises sleep quality through a standardized questionnaire,
which can be easily understood and answered, differentiating be-
tween ‘‘good sleepers’’ and ‘‘poor sleepers.’’ It assesses sleep quality
over a 1-month time interval. This is an intermediate period be-
tween those questionnaires that evaluate only the last night’s sleep
and cannot detect dysfunctional patterns, and those that evaluate
sleep quality over longer periods and cannot determine the severity
of a disorder at the present time. In addition, since its development,
the PSQI has been widely used to measure sleep quality in different
patient groups, such as in patients with renal and intestinal dis-
eases, with asthma and with cancer [9–13], and also in those with
psychiatric or sleep disorders. This way, the combination of quanti-
tative and qualitative information on sleep quality should be high-
lighted as an important feature of this questionnaire.
The present study was carried out to translate the PSQI and val-
idate its use in Brazil.
2. Patients and methods
2.1. Research tool
The PSQI assesses sleep quality over a 1-month period. The
questionnaire consists of 19 self-rated questions and 5 questions
that should be answered by bedmates or roommates. The latter
questions are used only for clinical information. The 19 questions
are categorized into 7 components, graded on a score that ranges
from 0 to 3. The PSQI components are as follows: subjective sleep
quality (C1), sleep latency (C2), sleep duration (C3), habitual sleep
efﬁciency (C4), sleep disturbances (C5), use of sleeping medication
(C6) and daytime dysfunction (C7). The sum of scores for these 7
components yields one global score, which ranges from 0 to 21,
where the highest score indicates worst sleep quality. A global PSQI
score greater than 5 indicates major difﬁculties in at least 2 com-
ponents or moderate difﬁculties in more than 3 components [8].
2.2. Translation
The PSQI was translated into Brazilian Portuguese by 2 indepen-
dent translators, who were aware of the study objectives. The
translations were compared by researchers until a ﬁnal version
could be obtained. Back-translations into English were carried
out by another 2 translators, who did not participate in any of
the previous steps. The author of the scale, Daniel J. Buysse, as-
sessed the back-translations and a ﬁnal version was then obtained.
The comparison of the PSQI with the ﬁnal back-translation was
made by individuals who were ﬂuent in English and who were not
involved in the research study. Each of the items in both versions
was analyzed following the method described in the literature
[6]. After this procedure, the ﬁnal version of the PSQI, in Brazilian
Portuguese, known as PSQI-BR, was obtained (see Appendix).
In order to assess the linguistic interchangeability between the
translation and the original questionnaire, a separate group of 14
bilingual individuals answered ﬁrstly the PSQI and then PSQI-BR
at 4 week intervals. Their scores on each version were correlated.
2.3. Patients
The PSQI-BR was applied to a group of consecutive patients
aged 18–65 years who underwent polysomnography (PSG) at the
Sleep Laboratory of Hospital de Clínicas de Porto Alegre (HCPA),Brazil, between January 2006 and September 2007. Those patients
were clinically diagnosed with depression, psychophysiological or
idiopathic insomnia or OSAS. The questionnaire was applied by a
previously trained researcher during sleep outpatient clinic visits,
which could precede PSG in at most 2 weeks. The depression group
was selected from patients under treatment at the outpatient clinic
of Psychiatry of HCPA who had scored 17 or more points on the
Hamilton [14] depression rating scale. For each patient data
regarding age, sex, body mass index (BMI), neck circumference
(cm), comorbidities, and use of medications were recorded.
Patients who could not understand the questions; those with
overlapping diagnoses, such as OSAS and depression; shift workers;
those with polysomnographic ﬁndings suggesting disorders other
than OSAS, insomnia or depression were excluded from the study.
The control group consisted of patients from the Outpatient
Clinic of Ophthalmology of HCPA as well as of hospital staff mem-
bers who did not have any sleep complaints and whose PSG ﬁnd-
ings were normal.
The diagnoses of OSAS and insomnia followed the standards
established by the American Academy of Sleep Medicine (AASM)
[15].
2.4. Statistical analysis
Quantitative variables were expressed as mean ± SD, and quali-
tative variables were expressed as percentage values. Two-tailed P
values of 0.05 or less were regarded as statistically signiﬁcant, and
95% conﬁdence intervals were calculated for results.
Group data are described by means and standard deviations
(SD). For comparisons between groups, an analysis of variance
(ANOVA) was performed. The effects of age, sex, body mass index
(BMI) and apnea–hypopnea index (AHI) on the PSQI-BR scores
were evaluated by analysis of covariance (ANCOVA). Internal con-
sistency of the PSQI-BR was assessed by Cronbach’s a statistics. A
probability of p < 0.05 was considered statistically signiﬁcant. Data
were analyzed by the Statistical Package for the Social Sciences for
Windows (SPSS), version 12.0.
2.5. Ethical aspects
The study protocol was approved by the Research Ethics Com-
mittee of the Graduate Research Program (GPPG) of Hospital de
Clínicas de Porto Alegre (HCPA), in accordance with International
and National Guidelines.
All patients and controls signed an informed consent form be-
fore inclusion in the study.3. Results
3.1. Cross-cultural adaptation
No structural modiﬁcations to the questionnaire were necessary
during the cross-cultural adaptation process. After the analysis of
the translations, the authors decided to keep the translation of
the term ‘‘bad dreams’’ in the item ‘‘Had bad dreams,’’ as we con-
sidered that not only nightmares could interfere with sleep quality,
but negative dreams could have the same effect. We added exam-
ples of activities in the item ‘‘During the past month, how often
have you had trouble staying awake while driving, eating meals,
or engaging in social activity?’’ since we believed respondents
could have some difﬁculty understanding which activities were in-
volved. In the question ‘‘During the past month, how much of a
problem has been for you to keep up enough enthusiasm to get
things done,’’ we added the expression ‘‘your habitual activities’’
between brackets.
Fig. 1. Box plots demonstrating median, upper and lower quartils, minimum and
maximum PSQI-BR scores for each group of patients and control group.
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swered by 14 bilingual individuals, yielded means (±SD) of
6.1 ± 3.4 and 5.6 ± 3.3, respectively, showing signiﬁcant correla-
tions (r = 0.881; CCI = 0.878; p < 0.001) and indicating a good lin-
guistic interchangeability between the translation and the
original questionnaire. The internal consistency of the PSQI-BR
and of the original PSQI, measured by Cronbach’s a coefﬁcient,
amounted to 0.73 and 0.75, respectively, when applied to this
group of bilingual individuals.
3.2. Characteristics of the groups and their respective PSQI-BR scores
A total of 83 patients and 21 controls completed the question-
naire and were included in the study after being submitted to over-
night polysomnography. The demographic characteristics of these
patients and controls are listed in Table 1. The 83 patients were
classiﬁed into the following groups: 19 in the depression group,
21 in the insomnia group, and 43 in the OSAS group. The mean
score for the Hamilton depression rating scale among patients with
depression was 20.9 ± 3.3 (±SD).
The 7-component scores of the PSQI-BR had an overall reliability
coefﬁcient (Cronbach’sa) of 0.82, indicatingahighdegreeof internal
consistency. Themean (±SD) PSQI-BR score was 2.5 ± 2.0 for control
subjects, 8.1 ± 4.0 for OSAS, 12.8 ± 3.7 for insomnia, 14.5 ± 3.7 for
depression. The one-way ANOVA demonstrated signiﬁcant differ-
ences in PSQI-BR scores across the 4 diagnostic groups (p < 0.001).
Post hoc tests between the paired groups revealed that the PSQI-
BR scores for OSAS, depression and insomnia were signiﬁcantly
higher than for the controls (p < 0.05). The scores for the insomnia
group did not differ from those of the depression group (p > 0.05),
but both were higher than in the OSAS group (p < 0.05).
All patients in the insomnia and depression groups had scores
greater than 5, and 31 of 43 patients (72.1%) with OSAS had scores
greater than 5, as shown in Fig. 1. Note that only one individual in
the control group had a score greater than 5.
The one-way ANOVA showed signiﬁcant difference in terms of
age across the 4 groups (p < 0.001). Post hoc tests between the
paired groups showed signiﬁcant differences between the OSAS
and depression groups comparatively to controls (p < 0.05) and be-
tween the OSAS and insomnia groups (p < 0.05). But there was a
weak correlation between age and the PSQI-BR scores (r = 0.254;
p = 0.009).
The analysis of covariance (ANCOVA) showed that the differ-
ences in PSQI-BR scores across the diagnostic groups were statisti-
cally signiﬁcant even after the adjustments for age, sex, sleep
efﬁciency, AHI, and sleep latency (p < 0.001).
No correlations were observed between the PSQI-BR scores and
the nadir oxygen saturation (p = 0.48) and between the PSQI-BR
scores and AHI (p = 0.56).Table 1
Characteristics of the groups and their respective PSQI-BR scores.*
Depression (n = 19) Insomnia
Age (years) 45.4 ± 10.3
(19–60)
40.9 ± 12.
(18–61)
Female/male 15/4 14/7
BMI (kg/m2) 26.9 ± 7.1
(16.7–47.0)
24.2 ± 2.9
(17.4–30
AHI 1.83 ± 1.36
(0.2–4.8)
0.68 ± 0.9
(0–3.7)
PSQI-BR Score 14.5 ± 3.7a,b,c
(6–20)
12.8 ± 3.7
(8–20)
OSAS, obstructive sleep apnea–hypopnea syndrome; AHI, apnea–hypopn
* Data are presented as mean ± SD (range) unless otherwise stated.
a p < 0.05 compared with controls group.
b p < 0.05 compared with OSAS group.
c p > 0.05 compared with insomnia group.There was a weak correlation between sleep latency obtained
by PSG and C2 (sleep latency) assessed by the PSQI-BR (r = 0.201;
p < 0.05). The same occurred between sleep efﬁciency obtained
by PSG and C4 (habitual sleep efﬁciency) assessed by the PSQI-
BR (r = 0.201; p < 0.05).4. Discussion
The scores for the PSQI-BR, measured by Cronbach’s a coefﬁ-
cient components, showed good internal consistency, i.e., each of
the 7 components of the questionnaire assesses a particular aspect
of sleep quality. Similar internal consistencies were obtained by
other validation studies of the PSQI-BR in other languages
[16,17]. The application of the questionnaire to the group of bilin-
gual individuals helped to demonstrate the good linguistic inter-
changeability between the translation and the original
questionnaire. The PSQI-BR also showed adequate psychometric
properties, which allow its application to different groups of pa-
tients, such as the ones assessed in the present study.
Submitting all study participants to PSG was a determining fac-
tor in the selection of the groups. This allowed excluding patients
with depression or insomnia who had a concomitant diagnosis of
OSAS. PSG also permitted a more accurate assessment of controls,(n = 21) OSAS (n = 43) Controls (n = 21)
8 49.9 ± 9.1
(27–65)
36.1 ± 8.0
(23–46)
19/24 12/9
.1)
30.9 ± 7.0
(18.3–58.4)
23.0 ± 2.7
(18.4–29.2)
3 30.39 ± 24.78
(5.5–104.8)
0.77 ± 0.95
(0–3.7)
a,b 8.1 ± 4.0a
(2–17)
2.5 ± 2.0
(0–8)
ea index; BMI, body mass index.
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ings, even if they were seemingly unrelated to clinical conditions.
The mean PSQI-BR scores were similar to those of the original
questionnaire in the control group. As with the OSAS, insomnia
and depression groups, the mean PSQI-BR scores were higher than
those obtained by Buysse et al. [8]. These dissimilar ﬁndings may
be ascribed to the differences between groups, since the diagnostic
criteria used for the development of the PSQI were established
according to the classiﬁcation of 1979 [18], whereas in this study,
the OSAS and insomnia groups were deﬁned according to AASM
criteria [15]. In any case, the results obtained with the original
questionnaire regarding the comparison between groups were
reproduced in the present study, i.e., the scores achieved by control
individuals were signiﬁcantly different from those of the OSAS,
depression and insomnia groups, and the scores for the insomnia
and depression groups were higher than those for the OSAS group.
The fact that the scores for the insomnia group were not signiﬁ-
cantly different from those of the depression group, as Buysse
et al. [8] had found, comes as no surprise, since insomnia is the
most common sleep disorder among patients with depression.
As in the study for the development of the PSQI and further
publications [8,19], the PSQI-BR scores were not correlated with
polysomnographic ﬁndings. The different sleep patterns observed
every night and the effect of spending the ﬁrst night in a sleep lab-
oratory may be related to the differences between polysomno-
graphic ﬁndings and the subjective sleep parameters. Also, it
should be highlighted that the questionnaire assessed sleep quality
over the past month and that it is not sensitive to daily ﬂuctuations
in sleep patterns.
Selecting diverse groups for this study apparently did not inter-
fere with the results, since such results were similar to those ob-
tained in other PSQI validation studies.Appendix Índice. de qualidade de sono de Pittsburgh (PSQI-BR)
Nome:_________________________________________________ Idade:_
Instruções:
As seguintes perguntas são relativas aos seus hábitos de sono d
lembrança mais exata da maioria dos dias e noites do último mês. Po
1. Durante o último mês, quando você geralmente foi para a cama
Hora usual de deitar ___________________
2. Durante o último mês, quanto tempo (em minutos) você geralme
Número de minutos ___________________
3. Durante o último mês, quando você geralmente levantou de man
Hora usual de levantar ____________________
4. Durante o último mês, quantas horas de sono você teve por noit
cama).
Horas de sono por noite _____________________
Para cada uma das questões restantes, marque a melhor (uma) res
5. Durante o último mês, com que freqüência você teve diﬁculdade
(a) Não conseguiu adormecer em até 30 minutos
Nenhuma no último mês _____ Menos de 1 vez/ semana _____
1 ou 2 vezes/ semana _____ 3 ou mais vezes/ semana _____
(b) Acordou no meio da noite ou de manhã cedo
Nenhuma no último mês _____ Menos de 1 vez/ semana _____
1 ou 2 vezes/ semana _____ 3 ou mais vezes/ semana _____
(c) Precisou levantar para ir ao banheiro
Nenhuma no último mês _____ Menos de 1 vez/ semana _____
1 ou 2 vezes/ semana _____ 3 ou mais vezes/ semana _____
(d) Não conseguiu respirar confortavelmente
Nenhuma no último mês _____ Menos de 1 vez/ semana _____The discriminatory power of the PSQI-BR between ‘‘good sleep-
ers’’ and ‘‘poor sleepers’’ was properly demonstrated by the results
of the present study. By using a cutoff score of 5, as recommended
in the original study [8], one observes that all patients diagnosed
with insomnia or depression had scores greater than 5, which sug-
gests poor sleep quality. Nevertheless, 12 out of 43 patients with
OSAS (27.9%) had scores lower than 5. This ﬁnding may be related
to the fact that poor sleep quality is not the major complaint by pa-
tients with OSAS, as it is common knowledge that these patients
usually seek medical care due to snoring and apnea [20]. In addi-
tion, one should take into account that the PSQI-BR is a subjective
tool for the assessment of sleep quality and, therefore, it is open to
individual interpretations.5. Conclusions
The results of the present study demonstrate that the PSQI-BR is
a valid and reliable instrument for the assessment of sleep quality,
being equivalent to its original version when applied to individuals
who speak Brazilian Portuguese. The PSQI-BR can be easily under-
stood and answered combined with the advantage of allowing
differentiation between ‘‘good sleepers’’ and ‘‘poor sleepers.’’
Therefore, given its considerable advantage of combining quantita-
tive and qualitative sleep data, the PSQI-BR is useful for the assess-
ment of patients with disorders that are likely to affect sleep
quality.6. Disclosure statement
The authors report no conﬂicts of interest.____ Data:____________
urante o último mês somente. Suas respostas devem indicar a
r favor, responda a todas as perguntas.
à noite?
nte levou para dormir à noite?
hã?
e? (Este pode ser diferente do número de horas que você ﬁcou na
posta. Por favor, responda a todas as questões.
de dormir porque você...
1 ou 2 vezes/ semana _____ 3 ou mais vezes/ semana _____
(e) Tossiu ou roncou forte
Nenhuma no último mês _____ Menos de 1 vez/ semana _____
1 ou 2 vezes/ semana _____ 3 ou mais vezes/ semana _____
(f) Sentiu muito frio
Nenhuma no último mês _____ Menos de 1 vez/ semana _____
1 ou 2 vezes/ semana _____ 3 ou mais vezes/ semana _____
(g) Sentiu muito calor
Nenhuma no último mês _____ Menos de 1 vez/ semana _____
1 ou 2 vezes/ semana _____ 3 ou mais vezes/ semana _____
(h) Teve sonhos ruins
Nenhuma no último mês _____ Menos de 1 vez/ semana _____
1 ou 2 vezes/ semana _____ 3 ou mais vezes/ semana _____
(i) Teve dor
Nenhuma no último mês _____ Menos de 1 vez/ semana _____
1 ou 2 vezes/ semana _____ 3 ou mais vezes/ semana _____
(j) Outra(s) razão(ões), por favor descreva _______________________________
Com que freqüência, durante o último mês, você teve diﬁculdade para dormir devido a essa razão?
Nenhuma no último mês _____ Menos de 1 vez/ semana _____
1 ou 2 vezes/ semana _____ 3 ou mais vezes/ semana _____
6. Durante o último mês, como você classiﬁcaria a qualidade do seu sono de uma maneira geral?
Muito boa _____
Boa _____
Ruim ____
Muito ruim _____
7. Durante o último mês, com que freqüência você tomou medicamento (prescrito ou ‘‘por conta própria’’) para lhe ajudar a dormir?
Nenhuma no último mês _____ Menos de 1 vez/ semana _____
1 ou 2 vezes/ semana _____ 3 ou mais vezes/ semana _____
8. No último mês, com que freqüência você teve diﬁculdade de ﬁcar acordado enquanto dirigia, comia ou participava de uma atividade
social (festa, reunião de amigos, trabalho, estudo)?
Nenhuma no último mês _____ Menos de 1 vez/ semana _____
1 ou 2 vezes/ semana _____ 3 ou mais vezes/ semana _____
9. Durante o último mês, quão problemático foi para você manter o entusiasmo (ânimo) para fazer as coisas (suas atividades habituais)?
Nenhuma diﬁculdade _____
Um problema leve _____
Um problema razoável _____
Um grande problema _____
10. Você tem um(a) parceiro [esposo(a)] ou colega de quarto?
Não ____
Parceiro ou colega, mas em outro quarto ____
Parceiro no mesmo quarto, mas não na mesma cama ____
Parceiro na mesma cama ____
Se você tem um parceiro ou colega de quarto, pergunte a ele/ela com que freqüência, no último mês, você teve ...
(a) Ronco forte
Nenhuma no último mês _____ Menos de 1 vez/ semana _____
1 ou 2 vezes/ semana _____ 3 ou mais vezes/ semana _____
(b) Longas paradas na respiração enquanto dormia
Nenhuma no último mês _____ Menos de 1 vez/ semana _____
1 ou 2 vezes/ semana _____ 3 ou mais vezes/ semana _____
(c) Contrações ou puxões nas pernas enquanto você dormia
Nenhuma no último mês _____ Menos de 1 vez/ semana _____
1 ou 2 vezes/ semana _____ 3 ou mais vezes/ semana _____
(d) Episódios de desorientação ou confusão durante o sono
Nenhuma no último mês _____ Menos de 1 vez/ semana _____
1 ou 2 vezes/ semana _____ 3 ou mais vezes/ semana _____
(e) Outras alterações (inquietações) enquanto você dorme; por favor, descreva _____________________________________
____________________________
Nenhuma no último mês _____ Menos de 1 vez/ semana _____
1 ou 2 vezes/ semana _____ 3 ou mais vezes/ semana ____
74 A.N. Bertolazi et al. / Sleep Medicine 12 (2011) 70–75
A.N. Bertolazi et al. / Sleep Medicine 12 (2011) 70–75 75Conﬂict of Interest
The ICMJE Uniform Disclosure Form for Potential Conﬂicts of
Interest associated with this article can be viewed by clicking on
the following link: doi:10.1016/j.sleep.2010.04.020.
References
[1] Antonelli IR, Marra C, Salvigni BL, Petrone A, Gemma A, Selvaggio D, et al. Does
cognitive disfunction conform to a distinctive pattern in obstructive sleep
apnea syndrome? J Sleep Res 2004;13(1):79–86.
[2] American Academy of Sleep Medicine Task Force. Sleep-Related breathing
disorders in adults: recommendations for syndrome deﬁnition and
measurement techniques in clinical research. Sleep 1999;22:667–89.
[3] Reimer MA, Flemons WW. Quality of life in sleep disorders. Sleep Med Rev
2003;7:335–49.
[4] Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-
related quality of life measures: literature review and proposed guidelines. J
Clin Epidemiol 1993;46(12):1417–32.
[5] Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of
cross-cultural adaptation of self-report measures. Spine 2000;25(24 Suppl.):
3186–91.
[6] Sperber AD. Translation and validation of study instruments for cross-cultural
research. Gastroenterology 2004;126(1):S124–8.
[7] Weaver TE. Outcome measurement in sleep medicine practice and research.
Part I: assessment of symptoms, subjective and objective daytime sleepiness,
health-related quality of life and functional status. Sleep Med Rev
2001;5(2):103–28.
[8] Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep
Quality Index: a new instrument for psychiatric practice and research.
Psychiatry Res 1989;28:193–213.[9] SabbatiniM, CrispoA, Pisani A,Gallo A. Sleepquality in renal transplant patients:
a never investigated problem. Nephrol Dial Transplant 2005;20(1):194–8.
[10] Costa DD, Bernatsky S, Dritsa M. Determinants of sleep quality in women with
systemic lúpus erythematosus. Arthritis Rheum 2005;53(2):272–8.
[11] Ranjbaran Z, Keefer L, Farhadi A, Stepanski E, Sedghi S, Keshavarzian A. Impact
of sleep disturbances in inﬂammatory bowel disease. J Gastroenterol Hepatol
2007;22(11):1748–53.
[12] Yuksel H, Sogut A, Yilmaz O, Demet M, Ergin D, Kirmaz C. Evaluation of sleep
quality and anxiety–depression parameters in asthmatic children and their
mothers. Respir Med 2007;101(12):2550–4.
[13] Mystakidou K, Parpa E, Tsilika E, Pathiaki M, Gennatas K, Smyrniotis V, et al.
The relationship of subjective sleep quality, pain, and quality of life in
advanced cancer patients. Sleep 2007;30(6):737–42.
[14] Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry
1960;23:56–62.
[15] American Academy of Sleep Medicine: International Classiﬁcation on Sleep
Disorders: Diagnostic and Coding Manual, 2nd ed. Wetchester, IL: American
Academy of Sleep Medicine; 2005.
[16] Escobar-Cordoba F, Eslava-Schmalbach J. Colombian validation of the
Pittsburgh Sleep Quality Index. Rev Neurol 2005;40(3):150–5.
[17] Backhaus J, Junghanns K, Broocks A, Riemann D, Hohagen F. Test–retest
reliability and validity of the Pittsburgh Sleep Quality Index in primary
insomnia. J Psychosom Res 2002;53(3):737–40.
[18] Association of Sleep Disorders Centers. Diagnostic Classiﬁcation of Sleep and
Arousal Disorders. 1st ed., prepared by the Sleep Disorders Committee,
Hoffwarg HP, Chairman. Sleep 1979;2:1–37.
[19] Buysse DJ, Reynolds CF, Monk TH, Hoch CC, Yeager AL, Kupfer DJ.
Quantiﬁcation of subjective sleep quality in healthy elderly men and
women using the Pittsburgh Sleep Quality Index (PSQI). Sleep 1991;14(4):
331–4.
[20] Kryger MH, Roth T, Dement WC, editors. Principles and practice of sleep
medicine, 4th ed.. Philadelphia: WB Saunders; 2005.
